Achievement of international normalized ratio therapeutic range among chronic non-valvular atrial fibrillation patients treated with warfarin

被引：0
|
作者：
Harley, CR
Shetty, S
Hauch, O
Wygant, G
Riedel, AA
Nelson, M
机构：
[1] Ingenix, Eden Prairie, MN USA
[2] AstraZeneca LP, Wilmington, DE USA
来源：
CIRCULATION | 2004年 / 109卷 / 20期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P204
引用
收藏
页码：E271 / E271
页数：1
相关论文
共 50 条
  • [21] International normalised ratio stability in patients aged 80 years and over taking warfarin for non-valvular atrial fibrillation
    Porter, A.
    Kennard, D.
    Lang, S. -J.
    Levy, S.
    Wang, Q.
    Chua, E.
    EUROPEAN GERIATRIC MEDICINE, 2016, 7 (05) : 411 - 415
  • [22] Barriers to using warfarin in non-valvular atrial fibrillation
    Gattellari, M
    Zwar, NA
    Worthington, JM
    Middleton, S
    BRITISH MEDICAL JOURNAL, 2006, 332 (7536): : 303 - 304
  • [23] Utilization of warfarin in elderly patients with non-valvular atrial fibrillation.
    Youssef, H
    Pomerantz, SC
    Ciesielski, J
    Cavalieri, TA
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S112 - S112
  • [24] DISCONTINUATION/INTERRUPTION OF WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Wang, J.
    Qiao, Y.
    Spivey, C. A.
    Liu, X.
    Phatak, H.
    Mardekian, J.
    Claflin, A. B.
    Kachroo, S.
    Abdulsatter, Y.
    Parker, R. B.
    VALUE IN HEALTH, 2014, 17 (07) : A763 - A763
  • [25] PROVIDER INTERPRETATION AND UTILIZATION OF TIME IN THERAPEUTIC RANGE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Brunton, Nichole
    Rouzbehani, Jahangir
    Sostin, Oleg
    Wakefield, Dorothy
    Galin, Ira
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2104 - 2104
  • [26] Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation
    Nelson, Winnie W.
    Song, Xue
    Coleman, Craig I.
    Thomson, Erin
    Smith, David M.
    Damaraju, C. V.
    Schein, Jeffrey R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (12) : 2461 - 2469
  • [27] Impact of stroke risk factors on warfarin prescription among patients with non-valvular atrial fibrillation
    Zhao, Yu-Hui
    Zhang, Ting
    Du, Xin
    Wen, Dan
    Shang, Mei-Sheng
    Ma, Chang-Sheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (08): : 16587 - 16595
  • [28] Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist
    Farag, Shereen Ibrahim
    Arafa, Osama Sanad
    Hassan, Amal Abou Elfadl
    Mashhour, Haldy Magdy
    Bendary, Ahmed Mahmoud
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2020, 16 (04) : 522 - 527
  • [29] REVIEW OF TIME IN THERAPEUTIC RANGE ON WARFARIN FOR NON-VALVULAR ATRIAL FIBRILLATION (NVAF) IN ADMISSIONS TO A GERIATRIC MEDICINE WARD
    Bhat, M.
    Jegard, J.
    Kaneshamoorthy, M.
    Yeo, J. H.
    O'Brien, A.
    AGE AND AGEING, 2018, 47 : 3 - 3
  • [30] Comparative Effectiveness of Dabigatran versus Warfarin in Patients With Non-Valvular Atrial Fibrillation
    Alonso, Alvaro
    Chen, Lin Y.
    MacLehose, Richard F.
    Lutsey, Pamela L.
    CIRCULATION, 2013, 128 (22)
12345